and explanation to the potential buyer are essential to proper delivery of this professional service.3–5 Furthermore, recognize that equine melanoma is
LESSONS LEARNED: AN INTERACTIVE SESSION WITH THE AAEP PAST PRESIDENTS References
1. Johnson PJ. Dermatologic tumors. Vet Clin North Am Equine Pract 1998;14;643–660.
always a potential metastatic malignancy that will behave unpredictably. Avoid predicting its future or taking it for granted. Although there may be a tendency to dismiss one or a few solitary small mel- anomas at the time of the pre-purchase examination as of minimal or no long-term significance, espe- cially in an otherwise excellent prospect, such an approach is both risky and medically untrue. This casual assessment can lead to serious repercussions in the future.
2. Fintl C, Dixon PM. A review of five cases of parotid melanoma in the horse. Equine Vet Educ 2001;3;43–50.
3. Moyer W, Werner H. Purchase examination guidelines for risk reduction. In: Forensics and Risk Management Proceed- ings of the 70th Western Veterinary Conference. Las Vegas, Nevada; 1998:92–98.
4. Moyer W, Werner H. Risk reduction in the reporting of the purchase examination, in Proceedings. Am Assoc Equine Pract 1999;45:24–26.
5. Vaughan JT. Professional liability in equine practice, risk management and loss control, in Proceedings. Am Assoc Equine Pract 2008;54:112.
